Consortium bibliometric analysis of hotspots and frontiers of immunotherapy in pancreatic cancer

Abstract excerpt

<h4>Background</h4> Pancreatic cancer is one of the most common malignant neoplasms with an increasing incidence, low rate of early diagnosis, and high degree of malignancy. In recent years, immunotherapy has made remarkable achievements in various cancer types including pancreatic cancer, due to the long-lasting antitumor responses elicited in human body. Immunotherapy mainly relies on mobilizing the host’s natu...

Topics

Open a Topic to create a Post that cites this publication.

• Carcinoma, Non-Small-Cell Lung
• Clinical Trials as Topic
• Immune Checkpoint Inhibitors
• Immunotherapy
• Mutation
• Neoplasms
• Proto-Oncogene Proteins p21(ras)
• Tumor Microenvironment

Identifiers and source

Literature Corpus work

970b8bb0-47d5-57fd-8c0b-8f7d6d828a56

DOI

10.1101/2022.11.10.515943